ENTITY
Pharmaessentia Corp

Pharmaessentia Corp (6446 TT)

83
Analysis
Health CareTaiwan
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.
more
26 Aug 2024 15:36

Taiwan Top 50 ETF Rebalance Preview: One Change Expected in Sep

PharmaEssentia could replace Nanya Tech in the Taiwan Top50 ETF. Shorts have been covering Pharmaessentia and building positions in Nanya Tech....

Logo
442 Views
Share
26 Aug 2024 07:05

TWSE Foreign Holding Weekly (Aug 23rd): Far Eastone Telecommunications

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in Far Eastone Telecommunications, Taiwan...

Logo
492 Views
Share
19 Aug 2024 07:05

TWSE Foreign Holding Weekly (Aug 16th): TSMC, Umc, Yageo, Evergreen Marine

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in TSMC, Umc, Yageo, Evergreen Marine.

Logo
268 Views
Share
12 Aug 2024 07:05

TWSE Foreign Holding Weekly (Aug 9th): TSMC, Hon Hai, Quanta Computer, Unimicron Tech, Mediatek

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in TSMC, Hon Hai, Quanta Computer, Unimicron Tech,...

Logo
249 Views
Share
12 Aug 2024 06:40

Taiwan Top 50 ETF Rebalance Preview: One Change Right at the Cusp

There could be one change for the Taiwan Top 50 ETF in September. Review cutoff is two weeks away and there are some stocks that are close to the...

Logo
363 Views
Share
x